The University of Missouri Laboratory for Infectious Disease Research has expanded to study SARS-CoV-2, the virus behind the COVID-19 epidemic. The 10,000-square foot building at the University of Missouri opened in 2010 with two-thirds of its funding from the...
University of Missouri
University of Missouri Investigator Leads Quest for Next Generation Gene Therapy for Duchenne Muscular Dystrophy
A prominent investigator at the University of Missouri School of Medicine received $200,000 in grants from four grassroots organizations to develop next generation gene therapy vectors for Duchenne muscular dystrophy (DMD). Dongsheng Duan, PhD, professor of...
Dr. Diana Gil Pagés of University of Missouri Commences Immunotherapy Preclinical Research with $3.7m
University of Missouri (UM) received a $3.7 million federal grant as part of a mission to produce a more effective immunotherapy treatment for cancer patients. Part of National Institutes of Health “Cancer MoonShot Initiative” UM now joins that effort in this next...
University of Missouri on the Move — Inks $133M Precision Health Tech Deal with Siemens
The University of Missouri and MU Health Care have signed a 10-year partnership with German health care technology company Siemens. The deal will drive the use of Siemens’ technology adoption within the University of Missouri and its health system—with a goal of...